AARDEX Group

AARDEX Group will be at the 2nd value added medicines conference 2018

medicines
NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines conference, Brussels, November 21, 2018

This event is organized by Medicines for Europe about ” an innovative approach for patients’ future”.

More on https://www.medicinesforeurope.com/events/vam2018/

Share This Post

You may also like...

Adherence - Guide for Sponsors and CROs
Breaking News

Electronic monitoring in clinical trials: a guide for sponsors and CROs

Clinical trials rely on accurate data. But what if one of the most important variables whether a patient actually takes the medication is based on guesswork? Traditional methods like pill counts, diaries, or verbal confirmation have long been the standard,

Medication adherence data in clinical trial dashboard
Breaking News

How poor adherence skews clinical trial results and what to do about it

Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In